Side-by-Side Comparison · 2026

Adipotide vs Mazdutide

Adipotide vs Mazdutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Adipotide
Metabolic & Mitochondrial

Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose vasculature, linked to a proapoptotic sequence that triggers cell death in the t...

Calculate Adipotide dose →
Mazdutide
Metabolic & Mitochondrial

Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-sensitizing effects of GLP-1 agonism with the fat-oxidizing and energy-expenditu...

Calculate Mazdutide dose →
Key Parameters
Parameter Adipotide Mazdutide
Category Metabolic & Mitochondrial Metabolic & Mitochondrial
Research Preclinical Phase III (China)
Half-Life - ~7 days
Typical Dose 1 mg/kg body weight 3–9 mg
Frequency Daily (research cycles) Once weekly
Route Subcutaneous Subcutaneous (weekly)
FDA Status Not Approved Not Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between Adipotide and Mazdutide?
Adipotide: Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose ... Mazdutide: Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-...
Which has a longer half-life, Adipotide or Mazdutide?
Adipotide half-life: unknown. Mazdutide half-life: ~7 days.
Can you stack Adipotide and Mazdutide?
Adipotide and Mazdutide are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.